USFDA18 May 2026, 10:46 am
FDC Ltd Receives USFDA Approval for Cefixime Oral Suspension
AI Summary
FDC Ltd has received ANDA approval from the United States Food and Drug Administration (U.S.FDA) for Cefixime for Oral Suspension USP, available in 100 mg / 5 mL and 200 mg/ 5 mL dosages. This approval allows FDC Ltd to manufacture and market this generic drug in the United States.
Key Highlights
- FDC Ltd granted ANDA approval by USFDA for Cefixime Oral Suspension.
- The approved drug is available in 100 mg/5 mL and 200 mg/5 mL dosages.
- This approval enables FDC to market the drug in the US market.